Search Results 211-220 of 17441 for monoclonal antibody
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior ...
These include secondary modification of CAR-T cells and combination strategies with monoclonal antibodies, small molecules, peptides and other immunotherapeutic ...
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as rituximab, can block ...
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Trastuzumab-qyyp is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
... monoclonal antibody (anti-PAPP-A) developed by Calico. These studies demonstrated an improvement in total kidney volume (TKV), reduction in cystic and tumor ...
The safety and efficacy of REGN5458, a monoclonal antibody, which has been used in people who already have been treated for multiple myeloma. Several ...
This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.